Kim Julie So-Young
President and CEO at TAK
- Sold, on record
- $1.5M
- Dollars the filings state
- Form 4 sales
- 1
- Latest Aug 10, 2026
- Form 144 notices
- 4
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- TAKTAKEDA PHARMACEUTICAL CO LTDPresident and CEO
Sales by reason
Form 4 sales per month, every sale on record.
Timeline
- 1 Form 144 notice TAKNoticeJul 10, 2023 2023
Filed to sell 29,403 shares ($455k)
Kim Julie So-Young, President, US Business Unit
No 10b5-1 planFirst sale on recordFiling
- 2 Form 144 notice TAKNoticeJul 10, 2024 +366 days
Filed to sell 37,219 shares ($491k)
Kim Julie So-Young, President, US Business Unit
No 10b5-1 planFirst sale on recordFiling
- 3 Form 144 notice TAKNoticeJul 9, 2025 +364 days
Filed to sell 58,559 shares ($903k)
Kim Julie So-Young, President, US Business Unit
No 10b5-1 planFirst sale on recordFiling
- 4 Form 144 notice TAKNoticeJul 13, 2026 +369 days
Filed to sell 96,558 shares ($1.6M)
Kim Julie So-Young, President and CEO
No 10b5-1 planFirst sale on recordFiling
- 5 Form 4 sale TAKNo planAug 10, 2026 +28 days
Sold 89,090 shares at $17.10 ($1.5M)
Kim Julie So-Young, President and CEO
No 10b5-1 planSold 18.5% of holdings ($8.2M position)391,489 shares leftFirst sale on recordFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | Aug 12, 2026 | TAK | President and CEO | Form 4 sale | 89,090 | $1.5M | 18.5% | No plan | SEC |
| Jul 13, 2026 | Jul 13, 2026 | TAK | President and CEO | Form 144 notice | 96,558 | $1.6M | Notice | SEC | |
| Jul 9, 2025 | Jul 9, 2025 | TAK | President, US Business Unit | Form 144 notice | 58,559 | $903k | Notice | SEC | |
| Jul 10, 2024 | Jul 10, 2024 | TAK | President, US Business Unit | Form 144 notice | 37,219 | $491k | Notice | SEC | |
| Jul 10, 2023 | Jul 10, 2023 | TAK | President, US Business Unit | Form 144 notice | 29,403 | $455k | Notice | SEC |